GMAB — GENMAB A/S

Ownership history in HARDING LOEVNER LP  ·  37 quarters on record

This page tracks every 13F SEC filing in which HARDING LOEVNER LP reported a position in GENMAB A/S (GMAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.91% (1999 Q1)
Avg. % of fund
0.55%
First filed
1999 Q1
Last filed
2025 Q4
Quarters held
37
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 3,370,143 -114,344 -3.3% 0.91% $103.9M $30.80
2025 Q3 ADDED 3,484,487 +561,048 +19.2% 0.78% $106.9M $30.67
2025 Q2 ADDED 2,923,439 +42,613 +1.5% 0.41% $60.4M $20.66
2025 Q1 ADDED 2,880,826 +637,434 +28.4% 0.43% $56.4M $19.58
33 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GMAB price (monthly, adj. close)

Other funds also holding GMAB

As of 2025 Q4 — sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.53% Orbis Allan Gray Ltd 3Y 7Y 1.86% AIMZ Investment Advisors, LLC 3Y 7Y 1.44% Private Wealth Advisors, LLC 3Y 1.3% Terra Nova Asset Management LLC 3Y 7Y 1.23% Avidity Partners Management LP 3Y 0.82% SUPERSTRING CAPITAL MANAGEMENT LP 0.48% VIRTUS ADVISERS, LLC 3Y 7Y 0.4% Perpetual Ltd 3Y 7Y 0.37% Dorsey Wright & Associates 3Y 7Y 0.3%
← Back to HARDING LOEVNER LP Holdings